Ranbaxy Innovation and Growth Focus

European Union Present in almost all the EU countries. Ranbaxy is ranked No.1 in its represented segment in Romania • Size of EU pharma market is $140 Bn with marginal growth of 2%. • West Europe has slowed down while East Europe is an emerging Pharma market. • West Europe is a bottom line focus market for Ranbaxy. • Focus is on profitability, not just market share. • East Europe is a growth market. • Russia is a growth market for Ranbaxy. • Ranbaxy is a leading Gx + OTC player in Romania. • Sales Grown as high as double digits. Manufacturing facility in Romania. RANBAXY Trusted medicines.Healthier lives 17

View entire presentation